Skip to main content
Fig. 1 | Cardio-Oncology

Fig. 1

From: Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines

Fig. 1

Study Cohort and Diagram. CMRI: cardiac magnetic resonance imaging; ALL: acute lymphocytic leukemia; AML: acute myeloid leukemia. Twenty patients (10–22 years) were prospectively enrolled between January 2013 and November 2014. Seventeen subjects completed visit 1 (30–60 mg/m2) and thirteen completed the remaining study visits (125–175 mg/m2, 200–250 mg/m2, 275–325 mg/m2, after max AC dose and 1 year after max AC dose)

Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us